“Precision Reprogramming of Lung Cancer Biomarkers via CRISPR/Cas9: A Paradigm Shift in Personalized Immunotherapy”, J. Anal. Oncol., vol. 14, pp. 96–105, Dec. 2025, doi: 10.30683/1927-7229.2025.14.15.